Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up.
about
Angioplasty for deep venous thrombosisEverolimus-eluting stents in interventional cardiologyIn-stent stenosis: pathology and implications for the development of drug eluting stentsSirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells.Bioresorbable scaffolds: a new paradigm in percutaneous coronary interventionNanoporous CREG-eluting stent attenuates in-stent neointimal formation in porcine coronary arteriesPercutaneous coronary intervention versus coronary artery bypass grafting for diabetics with multivessel coronary artery disease: the Korean Multicenter Revascularization Registry (KORR)Intracoronary brachytherapyDrug-eluting stent: a review and updateRedox regulation of the nutrient-sensitive raptor-mTOR pathway and complexMinimally invasive revascularization strategies for chronic lower limb ischemia.The Integrity bare-metal stent made by continuous sinusoid technology.Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stentLigand-based 3-D pharmacophore generation and molecular docking of mTOR kinase inhibitors.Dynamic adhesion of umbilical cord blood endothelial progenitor cells under laminar shear stress.Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosisMyocardial drug distribution generated from local epicardial application: potential impact of cardiac capillary perfusion in a swine model using epinephrine.Coronary artery stents: evaluating new designs for contemporary percutaneous intervention.Drug eluting stents: are human and animal studies comparable?Developments in restenosis.Bioresorbable polymeric stents: current status and future promise.Targeting the cell cycle machinery for the treatment of cardiovascular disease.Biocompatibility and biostability of metallic endovascular implants: state of the art and perspectives.Multi-vessel coronary disease and percutaneous coronary interventionSuperiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison.Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases.Early experiences and clinical implications of restenosis and drug-eluting stents: Part 2.Pulmonary vein stenosis: initial experience with cutting balloon angioplasty.Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis.Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives.Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.Targeting In-Stent-Stenosis with RGD- and CXCL1-Coated Mini-Stents in Mice.Comprehensive imaging of coronary artery disease: impact on contemporary treatment approaches.Percutaneous coronary revascularization in diabetics: from balloon angioplasty to drug-eluting stents.Drug eluting stents: an updated meta-analysis of randomised controlled trialsUpdate on drug-eluting stents for prevention of restenosis.Coronary artery restenosis: vascular biology and emerging therapeutic strategies.Treatment of allograft vasculopathy in heart transplantation.XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent.Gene therapy for the prevention of vein graft disease
P2860
Q24186975-A22ADE92-E5A4-4016-BC43-A9F19E7DB414Q24630321-998F21D5-DDB0-4C0F-BEDE-8A80E571709CQ24674571-996C2D27-3D98-4D0C-9370-6D0CF0AEA529Q24815293-57289FF0-B9E6-47E4-AED8-0495ADD626EAQ26766579-3D11912C-0B15-44FA-BA62-98B6C177CBCEQ27329486-9532AE48-B81D-47E6-95D7-0F1D42402E53Q28174081-F8A77A76-213B-40E5-A1A8-3317A21D4C22Q28193394-D565569F-BC01-4B86-9622-1F153E05C7B8Q28219254-2DD175EC-92CC-42D5-BC89-4BC1B5CF5E29Q28273915-64EF78FB-F031-48B2-A8C7-997BB9D7E35AQ33236821-47EB9383-85D0-412C-A5D4-D97DBC37AC4FQ33889866-AAD2315C-1BCF-4DEF-9C05-B8149BC043C0Q34044231-E1FCE8F8-DAE0-48CA-8534-CB98D3277461Q34205195-4A16F38F-EF0F-4C8D-B079-31BF8C0385D1Q34388631-0698AD7E-68E4-4878-9A7B-8405F662C11AQ34465141-DC437F88-F4F3-485A-A582-B9DB41AED63AQ34613676-5CD854DC-74AB-4766-9AAF-E734F65A7AE9Q34747489-AAEC6533-9F81-4331-950A-8FC362ABD085Q35044969-6C295945-3494-4D16-90B2-8DED384A4136Q35058624-D5E71539-C56D-4BED-BCB9-950A90D02153Q35127874-77A5525F-44A9-4060-8D83-3F119326B7AAQ35164884-FE415401-7C2C-4468-85BA-98652E5BBCD0Q35554290-8206819D-A702-4DBB-AB4C-71732B523FECQ35582152-53DFAFFB-F894-41BF-A27E-E8D54D59783BQ35584997-03D6502E-1518-455B-9780-24DD12F5CF45Q35696305-5A31183C-DDF1-4D80-A736-5C0F5D66929BQ35708574-52A18C0A-3794-4425-87EF-ADCDA4312F52Q35770926-CD7C4D05-55DB-4101-9F5E-AE133207265AQ35925484-3D9D229A-1B5E-48E7-87D3-0D09D33808E0Q35938663-D1B734DF-DDAA-4742-AA35-1C15CAD634EBQ35945466-2D2AE372-49D8-49A0-926E-D279B6DF91A0Q36021173-B0C2CB05-C91D-4D7D-AED1-D0245BCC0821Q36131805-7BCA19A5-213B-495D-B52B-86D6410D8BE6Q36216817-9E2F7A18-B7DA-4297-BA24-3414C625D2DEQ36282710-07D75AE0-1290-4FA4-A1C4-39DE18B97FA1Q36375853-CB80C1E8-4185-4160-ADEE-E885BDE47E5CQ36569798-244F6473-AFCB-4721-8C9A-BBD7B14CFB94Q36655174-FF9ADA2A-14A6-465E-A68A-EAD2B78D77F4Q36691665-ECA4C0D2-8E8F-4081-BBEE-D3A997A233F5Q36698258-CEBCBFD1-40DE-49E2-9777-4E39BC67C703
P2860
Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Sustained suppression of neoin ...... vascular ultrasound follow-up.
@en
Sustained suppression of neoin ...... vascular ultrasound follow-up.
@nl
type
label
Sustained suppression of neoin ...... vascular ultrasound follow-up.
@en
Sustained suppression of neoin ...... vascular ultrasound follow-up.
@nl
prefLabel
Sustained suppression of neoin ...... vascular ultrasound follow-up.
@en
Sustained suppression of neoin ...... vascular ultrasound follow-up.
@nl
P2093
P356
P1433
P1476
Sustained suppression of neoin ...... vascular ultrasound follow-up.
@en
P2093
Abizaid AC
Abizaid AS
Falotico R
Rensing BJ
Serruys PW
P304
P356
10.1161/HC4201.098056
P407
P577
2001-10-01T00:00:00Z